Deciphera Pharmaceuticals Ownership 2024 | Who Owns Deciphera Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

70.01%

Insider Ownership

28.48%

Retail Ownership

1.50%

Institutional Holders

177.00

Deciphera Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AMERICAN INTERNATIONAL GROUP, INC.----26,340-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----60,453-100.00%-Jun 30, 2024
US BANCORP \DE\----1,241-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----34,737-100.00%-Jun 30, 2024
HUNTINGTON NATIONAL BANK----653-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----223,187-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----17,910-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----515,955-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----15,355-100.00%-Jun 30, 2024
ROTHSCHILD INVESTMENT LLC----10-100.00%-Jun 30, 2024
STATE STREET CORP----3,098,806-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----822,515-100.00%-Jun 30, 2024
VANGUARD GROUP INC----4,565,044-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----288,635-100.00%-Jun 30, 2024
BARCLAYS PLC----88,521-100.00%-Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS----69,575-100.00%-Jun 30, 2024
FMR LLC----20,178-100.00%-Jun 30, 2024
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO----4,522-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----1,606,132-100.00%-Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----599-100.00%-Jun 30, 2024

Deciphera Pharmaceuticals's largest institutional shareholder is AMERICAN INTERNATIONAL GROUP, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AMERICAN INTERNATIONAL GROUP, INC.----26,340-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----60,453-100.00%-Jun 30, 2024
US BANCORP \DE\----1,241-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----34,737-100.00%-Jun 30, 2024
HUNTINGTON NATIONAL BANK----653-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----223,187-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----17,910-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----515,955-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----15,355-100.00%-Jun 30, 2024
ROTHSCHILD INVESTMENT LLC----10-100.00%-Jun 30, 2024
STATE STREET CORP----3,098,806-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----822,515-100.00%-Jun 30, 2024
VANGUARD GROUP INC----4,565,044-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----288,635-100.00%-Jun 30, 2024
BARCLAYS PLC----88,521-100.00%-Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS----69,575-100.00%-Jun 30, 2024
FMR LLC----20,178-100.00%-Jun 30, 2024
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO----4,522-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----1,606,132-100.00%-Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----599-100.00%-Jun 30, 2024

The largest Deciphera Pharmaceuticals shareholder by % of total assets is AMERICAN INTERNATIONAL GROUP, INC.. The company owns 0.00 shares of Deciphera Pharmaceuticals (DCPH), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ROTHSCHILD INVESTMENT LLC----10-100.00%-Jun 30, 2024
FIRST HORIZON ADVISORS, INC.----30-100.00%-Jun 30, 2024
PARALLEL ADVISORS, LLC----62-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----74-100.00%-Jun 30, 2024
CWM, LLC----83-100.00%-Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC----100-100.00%-Jun 30, 2024
CAPITAL ADVISORS, LTD. LLC----117-100.00%-Jun 30, 2024
LARSON FINANCIAL GROUP LLC----124-100.00%-Jun 30, 2024
GAMMA INVESTING LLC----143-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----233-100.00%-Jun 30, 2024
DAIWA SECURITIES GROUP INC.----272-100.00%-Jun 30, 2024
COMERICA BANK----289-100.00%-Jun 30, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.----400-100.00%-Jun 30, 2024
LINDBROOK CAPITAL, LLC----461-100.00%-Jun 30, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC----508-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----519-100.00%-Jun 30, 2024
NBC SECURITIES, INC.----586-100.00%-Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----599-100.00%-Jun 30, 2024
HUNTINGTON NATIONAL BANK----653-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----705-100.00%-Jun 30, 2024

As of Jun 30 2024, Deciphera Pharmaceuticals's largest institutional buyer is ROTHSCHILD INVESTMENT LLC. The company purchased -10.00 stocks of DCPH, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.----5,994,276-100.00%-Jun 30, 2024
ARMISTICE CAPITAL, LLC----5,900,000-100.00%-Jun 30, 2024
REDMILE GROUP, LLC----5,296,643-100.00%-Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----5,127,270-100.00%-Jun 30, 2024
VANGUARD GROUP INC----4,565,044-100.00%-Jun 30, 2024
STATE STREET CORP----3,098,806-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----1,962,841-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----1,606,132-100.00%-Jun 30, 2024
MORGAN STANLEY----1,539,826-100.00%-Jun 30, 2024
POLAR CAPITAL HOLDINGS PLC----1,500,000-100.00%-Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,455,837-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----1,425,282-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----1,254,317-100.00%-Jun 30, 2024
EMERALD ADVISERS, LLC----1,044,871-100.00%-Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST----824,402-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----822,515-100.00%-Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----809,923-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----797,100-100.00%-Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC----729,230-100.00%-Jun 30, 2024
BRAIDWELL LP----609,643-100.00%-Jun 30, 2024

As of Jun 30 2024, Deciphera Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -5.99M shares of DCPH, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.----5,994,276-100.00%-Jun 30, 2024
ARMISTICE CAPITAL, LLC----5,900,000-100.00%-Jun 30, 2024
REDMILE GROUP, LLC----5,296,643-100.00%-Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----5,127,270-100.00%-Jun 30, 2024
VANGUARD GROUP INC----4,565,044-100.00%-Jun 30, 2024
STATE STREET CORP----3,098,806-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----1,962,841-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----1,606,132-100.00%-Jun 30, 2024
MORGAN STANLEY----1,539,826-100.00%-Jun 30, 2024
POLAR CAPITAL HOLDINGS PLC----1,500,000-100.00%-Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,455,837-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----1,425,282-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----1,254,317-100.00%-Jun 30, 2024
EMERALD ADVISERS, LLC----1,044,871-100.00%-Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST----824,402-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----822,515-100.00%-Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----809,923-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----797,100-100.00%-Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC----729,230-100.00%-Jun 30, 2024
BRAIDWELL LP----609,643-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC----600,000-100.00%-Jun 30, 2024
NEW LEAF VENTURE PARTNERS, L.L.C.----576,975-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----531,475-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----530,200-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----515,955-100.00%-Jun 30, 2024
D. E. SHAW & CO., INC.----506,384-100.00%-Jun 30, 2024
DEUTSCHE BANK AG\----487,360-100.00%-Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC----471,977-100.00%-Jun 30, 2024
PANAGORA ASSET MANAGEMENT INC----417,064-100.00%-Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----398,540-100.00%-Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC----359,267-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP----312,426-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----294,229-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----288,635-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----279,047-100.00%-Jun 30, 2024
LAURION CAPITAL MANAGEMENT LP----274,634-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----250,889-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----242,056-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----223,187-100.00%-Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC----218,237-100.00%-Jun 30, 2024
PUBLIC SECTOR PENSION INVESTMENT BOARD----214,000-100.00%-Jun 30, 2024
BANK OF NEW YORK MELLON CORP----191,432-100.00%-Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC----182,059-100.00%-Jun 30, 2024
GHOST TREE CAPITAL, LLC----176,513-100.00%-Jun 30, 2024
UBS GROUP AG----166,438-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----160,690-100.00%-Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----152,000-100.00%-Jun 30, 2024
UBS OCONNOR LLC----151,796-100.00%-Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP----150,873-100.00%-Jun 30, 2024
ALGERT GLOBAL LLC----130,627-100.00%-Jun 30, 2024
CIBC WORLD MARKETS CORP----100,000-100.00%-Jun 30, 2024
SUNESIS ADVISORS, LLC----96,299-100.00%-Jun 30, 2024
BARCLAYS PLC----88,521-100.00%-Jun 30, 2024
JUPITER ASSET MANAGEMENT LTD----87,543-100.00%-Jun 30, 2024
TREXQUANT INVESTMENT LP----87,256-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----82,708-100.00%-Jun 30, 2024
AMERIPRISE FINANCIAL INC----81,688-100.00%-Jun 30, 2024
PDT PARTNERS, LLC----71,297-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----71,200-100.00%-Jun 30, 2024
MARTINGALE ASSET MANAGEMENT L P----69,926-100.00%-Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS----69,575-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----67,993-100.00%-Jun 30, 2024
NEBULA RESEARCH & DEVELOPMENT LLC----67,645-100.00%-Jun 30, 2024
INVESCO LTD.----65,578-100.00%-Jun 30, 2024
FISHER ASSET MANAGEMENT, LLC----62,372-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----60,453-100.00%-Jun 30, 2024
ALPHACENTRIC ADVISORS LLC----60,000-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----59,247-100.00%-Jun 30, 2024
ALPS ADVISORS INC----56,991-100.00%-Jun 30, 2024
ALLIANCEBERNSTEIN L.P.----54,000-100.00%-Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC----52,636-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----52,119-100.00%-Jun 30, 2024
RUSSELL INVESTMENTS GROUP, LTD.----47,531-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----45,036-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----40,170-100.00%-Jun 30, 2024
TUDOR INVESTMENT CORP ET AL----39,525-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----37,783-100.00%-Jun 30, 2024
DANA INVESTMENT ADVISORS, INC.----37,622-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----37,342-100.00%-Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC----36,480-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----34,737-100.00%-Jun 30, 2024
PROFUND ADVISORS LLC----34,220-100.00%-Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC----33,297-100.00%-Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----32,370-100.00%-Jun 30, 2024
MAN GROUP PLC----30,134-100.00%-Jun 30, 2024
XTX TOPCO LTD----29,016-100.00%-Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE----28,152-100.00%-Jun 30, 2024
METLIFE INVESTMENT MANAGEMENT, LLC----27,220-100.00%-Jun 30, 2024
J. GOLDMAN & CO LP----27,000-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC----26,539-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----26,340-100.00%-Jun 30, 2024
HSBC HOLDINGS PLC----26,256-100.00%-Jun 30, 2024
INSPIRE INVESTING, LLC----25,243-100.00%-Jun 30, 2024
VIRTUS ETF ADVISERS LLC----24,069-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----24,061-100.00%-Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC----23,832-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----23,724-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----23,377-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----23,002-100.00%-Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC----22,421-100.00%-Jun 30, 2024

Deciphera Pharmaceuticals's largest sold out institutional shareholder by shares sold is BLACKROCK INC., sold -5.99M shares, valued at -, as of undefined.

Deciphera Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Eaton Vance Enhanced Equity Income Fund II0.60%49,023--Mar 31, 2024
Manager Directed Portfolios0.47%76,772--Jan 31, 2024
Tema ETF Trust0.41%18,3592741.52%Feb 29, 2024
SPARROW FUNDS0.28%1,010--Feb 29, 2024
TEKLA HEALTHCARE INVESTORS0.26%223,631--Mar 31, 2024
MERIDIAN FUND INC0.22%511,315--Mar 28, 2024
Vanguard Montgomery Funds0.21%50,507--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.18%84,072--Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.18%1,509,018--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.12%23,795-6,588-21.68%Mar 28, 2024
ALGER FUNDS0.11%103,148--Jan 31, 2024
Federated Hermes MDT Series0.09%214,151--Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.08%418,672--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.08%42,310--Mar 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.07%231,600--Mar 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.06%53,044--Jan 31, 2024
BUFFALO FUNDS0.05%345,960--Mar 31, 2024
VANGUARD HORIZON FUNDS0.04%832,850-4,762-0.57%Mar 31, 2024
Humankind Benefit Corp0.03%74512920.94%Dec 31, 2023
VANGUARD EXPLORER FUND0.03%366,577--Jan 31, 2024
BlackRock Health Sciences Trust II0.03%77,670--Mar 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.03%96,883--Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.03%58,326--Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.02%73,284--Jan 31, 2024
Advantage Advisers Xanthus Fund, L.L.C.0.02%54,860--Mar 31, 2024
BNY Mellon Strategic Funds, Inc.0.02%35,756--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%93,519-2,907-3.01%Mar 31, 2024
ETFis Series Trust I0.01%20,606-854-3.98%Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%7,701-505-6.15%Mar 31, 2024
ACAP Strategic Fund0.01%188,560--Mar 31, 2024
AB CAP FUND, INC.0.01%423,571--Jan 31, 2024
PFM Multi-Manager Series Trust0.01%10,046--Dec 31, 2023
VALUED ADVISERS TRUST0.01%11,515--Jan 31, 2024
ALLSPRING VARIABLE TRUST0.01%7,227--Mar 31, 2024
EATON VANCE SPECIAL INVESTMENT TRUST0.01%18,245--Mar 31, 2024
UBS FUNDS0.01%49,172-737-1.48%Mar 31, 2024
IndexIQ ETF Trust0.01%21,056-1,474-6.54%Jan 31, 2024
Calvert Responsible Index Series, Inc.0.01%14,459--Mar 31, 2024
DEUTSCHE DWS INVESTMENT TRUST0.01%19,960--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%2,644,205-850,815-24.34%Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%397,200--Feb 29, 2024
SCHWAB CAPITAL TRUST0.01%233,9299,9394.44%Jan 31, 2024
Fidelity Commonwealth Trust II0.01%37,045--Aug 31, 2023
FINANCIAL INVESTORS TRUST0.01%434,143252,909139.55%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,209--Mar 31, 2024
Bernstein Fund Inc0.01%44,215--Mar 31, 2024
EATON VANCE GROWTH TRUST0.00%51,373--Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%18,113-1,510-7.70%Mar 31, 2024
ALPS ETF Trust0.00%53,697-1,978-3.55%Feb 29, 2024
SMALLCAP WORLD FUND INC0.00%270,000--Mar 31, 2024
North Square Investments Trust0.00%36,250-13,610-27.30%Feb 29, 2024
T. Rowe Price Equity Series, Inc.0.00%6,104--Mar 31, 2024
ETF Managers Trust0.00%27,678--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%9,510-315-3.21%Mar 31, 2024
AB VARIABLE PRODUCTS SERIES FUND, INC.0.00%15,650--Mar 31, 2024
JNL VARIABLE FUND LLC0.00%18,769--Mar 31, 2020
AMG Funds IV0.00%8,973--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%9,073--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%572,25854,73010.58%Feb 29, 2024
FIDELITY SECURITIES FUND0.00%243,100--Jan 31, 2024
FORUM FUNDS0.00%5,465--Jan 31, 2024
LORD ABBETT SECURITIES TRUST0.00%10,588--Jan 31, 2024
John Hancock Exchange-Traded Fund Trust0.00%13,643--Jan 31, 2024
Calvert Variable Products, Inc.0.00%5,166--Mar 31, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.00%375,249--Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%83,51134,77071.34%Mar 31, 2024
JANUS INVESTMENT FUND0.00%381,957--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%14,99811,969395.15%Mar 31, 2024
Franklin Custodian Funds0.00%573,931--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%33,930-2,714-7.41%Mar 31, 2024
AMG FUNDS0.00%30,800--Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%1,064,024113,40311.93%Jan 31, 2024
FIDELITY COVINGTON TRUST0.00%18,415-2,185-10.61%Jan 31, 2024
ProFunds0.00%11,4953,22038.91%Mar 31, 2024
Direxion Shares ETF Trust0.00%134,01724,21422.05%Jan 31, 2024
AMG FUNDS III0.00%4,484--Mar 28, 2024
Principal Exchange-Traded Funds0.00%9,858-810-7.59%Mar 31, 2024
Dimensional ETF Trust0.00%353,85615,3454.53%Jan 31, 2024
DEUTSCHE DWS VARIABLE SERIES II0.00%1,963--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%54,666--Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%711,501--Mar 31, 2024
SunAmerica Specialty Series0.00%308--Apr 30, 2021
VANGUARD QUANTITATIVE FUNDS0.00%2,800--Mar 31, 2024
ETF Series Solutions0.00%12,2901,96819.07%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%18,113-3,524-16.29%Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,541--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%297,21215,9075.65%Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%55,85621,36261.93%Feb 29, 2024
VANGUARD WORLD FUND0.00%120,374-13,222-9.90%Feb 29, 2024
OHIO NATIONAL FUND INC0.00%9,562--Mar 31, 2024
BlackRock ETF Trust0.00%407--Jan 31, 2024
DRIEHAUS MUTUAL FUNDS0.00%3,928--Mar 28, 2024
SSGA FUNDS0.00%181--Feb 29, 2024
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.00%5,677--Jan 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%12,78612,786-Mar 31, 2024
THRIVENT SERIES FUND INC0.00%42,083-4,995-10.61%Mar 28, 2024
DEUTSCHE DWS SECURITIES TRUST0.00%12,704--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%46,5101,2862.84%Mar 31, 2024
Managed Portfolio Series0.00%7,514--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%30,6359,76746.80%Mar 31, 2024

Deciphera Pharmaceuticals's largest mutual fund holder by % of total assets is "Eaton Vance Enhanced Equity Income Fund II", owning 49.02K shares, compromising 0.60% of its total assets.

Deciphera Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241777.27%
31 Dec, 231654.43%
30 Sep, 231588.22%
30 Jun, 23146-3.31%
31 Mar, 23151-0.66%
31 Dec, 22152-3.18%
30 Sep, 2215721.71%
30 Jun, 221293.20%
31 Mar, 22125-19.87%
31 Dec, 21156-12.85%
30 Sep, 2117913.29%
30 Jun, 21158-14.13%
31 Mar, 21184-8.46%
31 Dec, 2020112.92%
30 Sep, 20178-2.73%
30 Jun, 2018314.37%
31 Mar, 20160-5.33%
31 Dec, 1916929.01%
30 Sep, 1913142.39%
30 Jun, 199215.00%
31 Mar, 19801.27%
31 Dec, 1879-11.24%
30 Sep, 1889-1.11%
30 Jun, 189063.64%
31 Mar, 1855-6.78%
31 Dec, 175918.00%
30 Sep, 1750-

As of 31 Mar 24, 177 institutions are holding Deciphera Pharmaceuticals's shares, representing an increase of 7.27% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2459,551,8872.76%
31 Dec, 2357,953,4513.05%
30 Sep, 2356,236,3970.67%
30 Jun, 2355,860,893-3.73%
31 Mar, 2358,028,09510.95%
31 Dec, 2252,301,9426.51%
30 Sep, 2249,106,8642.20%
30 Jun, 2248,051,72310.16%
31 Mar, 2243,618,194-5.04%
31 Dec, 2145,933,8727.55%
30 Sep, 2142,707,965-1.75%
30 Jun, 2143,466,7630.26%
31 Mar, 2143,354,900-0.03%
31 Dec, 2043,369,5341.64%
30 Sep, 2042,668,649-0.31%
30 Jun, 2042,801,0875.15%
31 Mar, 2040,705,82314.00%
31 Dec, 1935,707,2270.72%
30 Sep, 1935,450,44953.17%
30 Jun, 1923,143,7612.93%
31 Mar, 1922,485,1912.65%
31 Dec, 1821,905,4093.05%
30 Sep, 1821,257,1982.19%
30 Jun, 1820,802,03133.21%
31 Mar, 1815,615,602-0.59%
31 Dec, 1715,708,1207.81%
30 Sep, 1714,570,860-

Deciphera Pharmaceuticals (DCPH) has 59.55M shares outstanding as of 31 Mar 24, up 2.76% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2470.01%1.51%
31 Dec, 2368.13%1.56%
30 Sep, 2366.14%1.45%
30 Jun, 2367.57%1.37%
31 Mar, 2370.19%1.50%
31 Dec, 2268.42%1.74%
30 Sep, 2262.79%1.41%
30 Jun, 2266.62%1.20%
31 Mar, 2274.41%1.19%
31 Dec, 2179.08%1.46%
30 Sep, 2173.50%1.31%
30 Jun, 2174.96%1.33%
31 Mar, 2175.08%1.27%
31 Dec, 2076.91%1.34%
30 Sep, 2075.67%1.29%
30 Jun, 2076.54%1.33%
31 Mar, 2075.99%1.10%
31 Dec, 1983.29%1.27%
30 Sep, 1980.93%2.20%
30 Jun, 1960.59%1.75%
31 Mar, 1958.88%1.54%
31 Dec, 1861.90%1.94%
30 Sep, 1856.45%1.47%
30 Jun, 1861.97%2.70%
31 Mar, 1847.91%0.55%
31 Dec, 1793.54%1.24%
30 Sep, 1786.77%-

As of 31 Mar 24, Deciphera Pharmaceuticals is held by 70.01% institutional shareholders, representing a 1.51% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2493-
31 Dec, 239324.00%
30 Sep, 237510.29%
30 Jun, 2368-18.07%
31 Mar, 238313.70%
31 Dec, 2273-20.65%
30 Sep, 229229.58%
30 Jun, 227120.34%
31 Mar, 2259-30.59%
31 Dec, 21853.66%
30 Sep, 218228.13%
30 Jun, 2164-22.89%
31 Mar, 2183-22.43%
31 Dec, 2010728.92%
30 Sep, 2083-19.42%
30 Jun, 2010313.19%
31 Mar, 2091-15.74%
31 Dec, 1910814.89%
30 Sep, 199470.91%
30 Jun, 195552.78%
31 Mar, 1936-23.40%
31 Dec, 1847-6.00%
30 Sep, 1850-26.47%
30 Jun, 1868119.35%
31 Mar, 1831-31.11%
31 Dec, 1745-10.00%
30 Sep, 1750-

93 institutional shareholders have increased their position in DCPH stock as of 31 Mar 24 compared to 93 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 245312.77%
31 Dec, 2347-14.55%
30 Sep, 235527.91%
30 Jun, 2343-
31 Mar, 2343-12.24%
31 Dec, 224940.00%
30 Sep, 2235-
30 Jun, 2235-16.67%
31 Mar, 224231.25%
31 Dec, 2132-37.25%
30 Sep, 2151-8.93%
30 Jun, 2156-
31 Mar, 21565.66%
31 Dec, 2053-
30 Sep, 205317.78%
30 Jun, 20457.14%
31 Mar, 204216.67%
31 Dec, 193663.64%
30 Sep, 192215.79%
30 Jun, 1919-26.92%
31 Mar, 192636.84%
31 Dec, 1819-17.39%
30 Sep, 182364.29%
30 Jun, 1814-12.50%
31 Mar, 181677.78%
31 Dec, 179-
30 Sep, 17--

53 institutional shareholders have reduced their position in DCPH stock as of 31 Mar 24 compared to 47 in the previous quarter (a 12.77% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241777.27%59,551,8872.76%70.01%1.51%93-5312.77%
31 Dec, 231654.43%57,953,4513.05%68.13%1.56%9324.00%47-14.55%
30 Sep, 231588.22%56,236,3970.67%66.14%1.45%7510.29%5527.91%
30 Jun, 23146-3.31%55,860,893-3.73%67.57%1.37%68-18.07%43-
31 Mar, 23151-0.66%58,028,09510.95%70.19%1.50%8313.70%43-12.24%
31 Dec, 22152-3.18%52,301,9426.51%68.42%1.74%73-20.65%4940.00%
30 Sep, 2215721.71%49,106,8642.20%62.79%1.41%9229.58%35-
30 Jun, 221293.20%48,051,72310.16%66.62%1.20%7120.34%35-16.67%
31 Mar, 22125-19.87%43,618,194-5.04%74.41%1.19%59-30.59%4231.25%
31 Dec, 21156-12.85%45,933,8727.55%79.08%1.46%853.66%32-37.25%
30 Sep, 2117913.29%42,707,965-1.75%73.50%1.31%8228.13%51-8.93%
30 Jun, 21158-14.13%43,466,7630.26%74.96%1.33%64-22.89%56-
31 Mar, 21184-8.46%43,354,900-0.03%75.08%1.27%83-22.43%565.66%
31 Dec, 2020112.92%43,369,5341.64%76.91%1.34%10728.92%53-
30 Sep, 20178-2.73%42,668,649-0.31%75.67%1.29%83-19.42%5317.78%
30 Jun, 2018314.37%42,801,0875.15%76.54%1.33%10313.19%457.14%
31 Mar, 20160-5.33%40,705,82314.00%75.99%1.10%91-15.74%4216.67%
31 Dec, 1916929.01%35,707,2270.72%83.29%1.27%10814.89%3663.64%
30 Sep, 1913142.39%35,450,44953.17%80.93%2.20%9470.91%2215.79%
30 Jun, 199215.00%23,143,7612.93%60.59%1.75%5552.78%19-26.92%
31 Mar, 19801.27%22,485,1912.65%58.88%1.54%36-23.40%2636.84%
31 Dec, 1879-11.24%21,905,4093.05%61.90%1.94%47-6.00%19-17.39%
30 Sep, 1889-1.11%21,257,1982.19%56.45%1.47%50-26.47%2364.29%
30 Jun, 189063.64%20,802,03133.21%61.97%2.70%68119.35%14-12.50%
31 Mar, 1855-6.78%15,615,602-0.59%47.91%0.55%31-31.11%1677.78%
31 Dec, 175918.00%15,708,1207.81%93.54%1.24%45-10.00%9-
30 Sep, 1750-14,570,860-86.77%-50---

Deciphera Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 20, 2024Sherman Matthew Lofficer EVP & Chief Medical OfficerS-SaleSell2,615$15.62$40.84K108,739
Feb 20, 2024Kelly Thomas Patrickofficer Chief Financial OfficerS-SaleSell3,010$15.62$47.01K80,350
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerS-SaleSell2,267$15.62$35.41K68,031
Feb 20, 2024Martin Daniel C.officer Chief Commercial OfficerS-SaleSell2,267$15.62$35.41K55,118

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 24, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneySell48,136$0.01$481.36-
Feb 20, 2024Sherman Matthew Lofficer EVP & Chief Medical OfficerS-SaleSell2,615$15.62$40.84K108,739
Feb 20, 2024Kelly Thomas Patrickofficer Chief Financial OfficerS-SaleSell3,010$15.62$47.01K80,350
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerS-SaleSell2,267$15.62$35.41K68,031
Feb 20, 2024Martin Daniel C.officer Chief Commercial OfficerS-SaleSell2,267$15.62$35.41K55,118
Feb 09, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneySell914,001$0.01$9.14K48,136

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 24, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneyBuy48,136$0.01$481.3623,107,844
Apr 24, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneySell48,136$0.01$481.36-
Feb 20, 2024Sherman Matthew Lofficer EVP & Chief Medical OfficerA-AwardBuy17,275--111,354
Feb 20, 2024Sherman Matthew Lofficer EVP & Chief Medical OfficerS-SaleSell2,615$15.62$40.84K108,739
Feb 20, 2024Sherman Matthew Lofficer EVP & Chief Medical OfficerA-AwardBuy69,100$15.92$1.10M69,100
Feb 20, 2024Kelly Thomas Patrickofficer Chief Financial OfficerA-AwardBuy17,275--83,360
Feb 20, 2024Kelly Thomas Patrickofficer Chief Financial OfficerS-SaleSell3,010$15.62$47.01K80,350
Feb 20, 2024Kelly Thomas Patrickofficer Chief Financial OfficerA-AwardBuy69,100$15.92$1.10M69,100
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerA-AwardBuy10,000--70,298
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerS-SaleSell2,267$15.62$35.41K68,031
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerA-AwardBuy9,725--60,298
Feb 20, 2024Pitman Jamaofficer SVP, Chief Development OfficerA-AwardBuy38,900$15.92$619.29K38,900
Feb 20, 2024Hoerter Steven L.director, officer President and CEOA-AwardBuy298,100$15.92$4.75M298,100
Feb 20, 2024Dhanak Dashyantofficer EVP & Chief Scientific OfficerA-AwardBuy17,275--158,175
Feb 20, 2024Dhanak Dashyantofficer EVP & Chief Scientific OfficerA-AwardBuy69,100$15.92$1.10M69,100
Feb 20, 2024Martin Daniel C.officer Chief Commercial OfficerA-AwardBuy9,725--57,385
Feb 20, 2024Martin Daniel C.officer Chief Commercial OfficerS-SaleSell2,267$15.62$35.41K55,118
Feb 20, 2024Martin Daniel C.officer Chief Commercial OfficerA-AwardBuy38,900$15.92$619.29K38,900
Feb 09, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneyBuy914,001$0.01$9.14K23,059,708
Feb 09, 2024Brightstar Associates LLC10 percent owner-X-InTheMoneySell914,001$0.01$9.14K48,136

The last insider sell of Deciphera Pharmaceuticals's stock was made by Brightstar Associates LLC on Apr 24 2024, selling 48,136 shares at $0.01 per share (valued at $481.36).

Deciphera Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202411100.00%
Q1 2024179188.89%
Q4 2023101283.33%
Q3 20233--
Q2 2023105200.00%
Q1 20231813138.46%
Q4 2022-1-
Q2 2022145280.00%
Q1 2022167228.57%
Q4 20211111100.00%
Q2 2021141687.50%
Q1 2021143342.42%
Q4 202082334.78%
Q3 2020183256.25%
Q2 2020202968.97%
Q1 2020216233.87%
Q4 20192422109.09%
Q3 201983324.24%
Q2 20191110110.00%
Q1 2019243275.00%

1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Deciphera Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-8-
Q4 2023-12-
Q3 2023---
Q2 20232540.00%
Q1 20231128.33%
Q4 2022-1-
Q2 20222540.00%
Q1 2022-5-
Q4 2021-1-
Q2 2021-10-
Q1 2021-13-
Q4 2020-14-
Q3 2020-20-
Q2 2020-18-
Q1 2020-39-
Q4 2019-12-
Q3 2019-26-
Q2 2019-5-
Q1 2019-15-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Deciphera Pharmaceuticals's stocks.

Deciphera Pharmaceuticals Peer Ownership


TickerCompany
SUPNSupernus Pharmaceuticals, Inc.
ANIPANI Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
NBIXNeurocrine Biosciences, Inc.
IRWDIronwood Pharmaceuticals, Inc.
SSICSilver Spike Investment Corp.
PROCProcaps Group S.A.
PBHPrestige Consumer Healthcare Inc.
ALKSAlkermes plc
EVOEvotec SE
COLLCollegium Pharmaceutical, Inc.
AVDLAvadel Pharmaceuticals plc
EGRXEagle Pharmaceuticals, Inc.
AMPHAmphastar Pharmaceuticals, Inc.

DCPH Ownership FAQ


Deciphera Pharmaceuticals is owned by institutional shareholders (70.01%), insiders (28.48%), and public (1.50%). The largest institutional shareholder of Deciphera Pharmaceuticals is AMERICAN INTERNATIONAL GROUP, INC. (0% of total shares) and the top mutual fund owner is Eaton Vance Enhanced Equity Income Fund II (0.60% of total shares).

Deciphera Pharmaceuticals's major institutional shareholders are AMERICAN INTERNATIONAL GROUP, INC., JPMORGAN CHASE & CO, US BANCORP \DE\, FRANKLIN RESOURCES INC, and HUNTINGTON NATIONAL BANK. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2024, there are 177 institutional shareholders of Deciphera Pharmaceuticals.

AMERICAN INTERNATIONAL GROUP, INC owns 0 shares of Deciphera Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).

As of Jun 2024, JPMORGAN CHASE & CO holds 0 shares of Deciphera Pharmaceuticals (DCPH), compromising 0% of the company, valued at $0.

US BANCORP \DE\ is the third largest holder of Deciphera Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).